Most Viewed Articles on GWDN Last Week: Jan 3, 2012

Jan 03, 2012

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

1) Class Action Lawsuit Filed Against Pacific Biosciences
2) Illumina Files Suit Alleging Ion Torrent Infringes IP
3) Affymetrix Sued by Investment Fund Over Pending eBioscience Deal
4) FY 2012 NIH Budget Includes $577M for NCATS
5) Complete Genomics Files $100M Shelf Registration

Breaking News

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Most Viewed Articles on GWDN Last Week: Jan 3, 2012

Vibrent Health, University of Maryland Medicine Partner for Population Health Initiative

Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows

Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features

Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle

Thermo Fisher Scientific Receives CE Mark for TaqPath COVID-19 RNase P 2.0 Testing Kit

Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test

Tennessee's COVID-19 Sequencing

Sanction Violation Charges

Prenetics to Go Public Through SPAC

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

Illumina Adds Seven Genomics Startups to Accelerator Program

Exact Sciences Stock Spikes After Primary Care Sales Team Nearly Doubles

Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger

Oxford Nanopore Technologies Registers for IPO on London Stock Exchange

Centenarian Exome Analysis Points to Conserved Longevity Pathways